Summary
Updated Aug 30, 2026
Jess Roper is Director of REVELATION BIOSCIENCES, INC. (REVB). 4 SEC Form 4 filings on record going back to 2025, most recently on 18 August 2026.
Recent Transactions
4Every recent SEC Form 4 transaction Jess Roper has reported, most recent first.
Most Active Insiders Right Now
Jess Roper has no co-filers on record, so these are insiders with the largest open-market activity across the market in the last 90 days.
- BX Mozart ML-2 Holdco L.P. - $1.22B of MDLN open-market activity in the last 90 days
- Hellman & Friedman Capital Partners X (Parallel), L.P. - $1.16B of MDLN open-market activity in the last 90 days
- James Michael Chu - $1.10B of BIRK open-market activity in the last 90 days
- SUMITOMO MITSUI FINANCIAL GROUP, INC. - $995.27M of JEF open-market activity in the last 90 days
- Uber Technologies, Inc - $950.85M of AUR open-market activity in the last 90 days
- KKR Group Partnership L.P. - $857.49M of BTSG open-market activity in the last 90 days
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Jess Roper?
Jess Roper is a corporate insider, tracked as Director of REVELATION BIOSCIENCES, INC. (REVB). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Jess Roper submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Where can I see all of Jess Roper's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Jess Roper and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
